Roberto Ronca
About
Roberto Ronca is a scholar working on Molecular Biology, Immunology and Organic Chemistry.
According to data from OpenAlex, Roberto Ronca has authored 116 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 29 papers in Immunology and 24 papers in Organic Chemistry. Recurrent topics in Roberto Ronca's work include Fibroblast Growth Factor Research (27 papers), Biomarkers in Disease Mechanisms (17 papers) and Angiogenesis and VEGF in Cancer (15 papers). Roberto Ronca is often cited by papers focused on Fibroblast Growth Factor Research (27 papers), Biomarkers in Disease Mechanisms (17 papers) and Angiogenesis and VEGF in Cancer (15 papers). Roberto Ronca collaborates with scholars based in Italy, United States and United Kingdom. Roberto Ronca's co-authors include Marco Presta, Marco Rusnati, Patrizia Dell’Era, Stefania Mitola, Emanuela Moroni, Arianna Giacomini, Daniela Coltrini, Vincenzo Bronte, Nicholas P. Restifo and Paola Zanovello and has published in prestigious journals such as Nature Communications, Physiological Reviews and Blood.
In The Last Decade
Roberto Ronca
113 papers receiving 4.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Roberto Ronca Italy | 35 | 3.0k | 1.4k | 882 | 805 | 559 | 116 | 5.0k | ||
| Qiang Wang China | 40 | 3.0k 1.0× | 864 0.6× | 1.4k 1.6× | 814 1.0× | 671 1.2× | 191 | 5.3k | ||
| Antonino Passaniti United States | 39 | 3.6k 1.2× | 699 0.5× | 1.1k 1.2× | 1.5k 1.8× | 691 1.2× | 85 | 5.6k | ||
| Karen E. Pollok United States | 38 | 2.7k 0.9× | 1.6k 1.2× | 1.7k 1.9× | 671 0.8× | 445 0.8× | 142 | 5.6k | ||
| Anna‐Karin Olsson Sweden | 28 | 2.7k 0.9× | 1.2k 0.9× | 1.1k 1.3× | 848 1.1× | 359 0.6× | 65 | 4.8k | ||
| Betty Chang United States | 35 | 4.4k 1.5× | 2.5k 1.9× | 1.9k 2.2× | 502 0.6× | 444 0.8× | 76 | 9.4k | ||
| Aldo M. Roccaro United States | 50 | 4.5k 1.5× | 1.3k 1.0× | 2.0k 2.2× | 1.7k 2.2× | 333 0.6× | 203 | 7.6k | ||
| Donald L. Durden United States | 38 | 3.3k 1.1× | 997 0.7× | 1.1k 1.3× | 1.0k 1.3× | 364 0.7× | 108 | 5.3k | ||
| Girolamo Ranieri Italy | 37 | 2.1k 0.7× | 1.4k 1.0× | 1.3k 1.4× | 604 0.8× | 211 0.4× | 123 | 4.5k | ||
| Diane R. Bielenberg United States | 40 | 3.1k 1.0× | 737 0.5× | 1.9k 2.1× | 1.1k 1.4× | 591 1.1× | 95 | 5.5k | ||
| Grazia Ambrosini United States | 27 | 4.8k 1.6× | 1.2k 0.9× | 2.2k 2.5× | 743 0.9× | 692 1.2× | 48 | 6.8k |
Countries citing papers authored by Roberto Ronca
Since
Specialization
Citations
This map shows the geographic impact of Roberto Ronca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Ronca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Ronca more than expected).
Fields of papers citing papers by Roberto Ronca
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Roberto Ronca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Ronca. The network helps show where Roberto Ronca may publish in the future.
Co-authorship network of co-authors of Roberto Ronca
This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Ronca. A scholar is included among the top collaborators of Roberto Ronca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Ronca. Roberto Ronca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mitola, Stefania, et al.. (2025). Protocol for performing angiogenic and tumorigenic assays using the in ovo chick embryo chorioallantoic membrane model. STAR Protocols. 6(1). 103663–103663.
2.
Carta, Fabrizio, Marialuigia Fantacuzzi, Ilaria D’Agostino, et al.. (2025). Pegylation approach applied to erlotinib–carbonic anhydrase inhibitors hybrids towards anticancer agents. RSC Medicinal Chemistry. 16(9). 4316–4339.
3.
Semeraro, Francesco, et al.. (2024). Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(3). 189104–189104.
4.
Miele, Dalila, Laura Catenacci, Milena Sorrenti, et al.. (2024). Collagen/PCL electrospun fibers loaded with polyphenols: Curcumin and resveratrol comparison. International Journal of Biological Macromolecules. 279(Pt 3). 135333–135333.
5.
Giovannuzzi, Simone, Andrea Angeli, Michaël Smietana, et al.. (2024). Benzoxaborinine, New Chemotype for Carbonic Anhydrase Inhibition: Ex Novo Synthesis, Crystallography, In Silico Studies, and Anti-Melanoma Cell Line Activity. Journal of Medicinal Chemistry. 67(20). 18221–18234.
6.
Bonardi, Alessandro, Alessio Nocentini, Paola Gratteri, et al.. (2023). Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studies. Bioorganic & Medicinal Chemistry. 94. 117467–117467.
7.
Spanò, Virginia, Roberta Bortolozzi, Marilia Barreca, et al.. (2022). Synthesis of 2H-Imidazo[2′,1':2,3] [1,3]thiazolo[4,5-e]isoindol-8-yl-phenylureas with promising therapeutic features for the treatment of acute myeloid leukemia (AML) with FLT3/ITD mutations. European Journal of Medicinal Chemistry. 235. 114292–114292.
8.
Rezzola, Sara, et al.. (2021). Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 280–286.
9.
Asperti, Michela, Elisabetta Grillo, Magdalena Gryzik, et al.. (2021). H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis. Free Radical Biology and Medicine. 169. 294–303.
10.
Romagnoli, Romeo, Paola Oliva, María Kimatrai Salvador, et al.. (2021). A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents. European Journal of Medicinal Chemistry. 214. 113229–113229.
11.
Belleri, Mirella, Daniela Coltrini, Roberto Ronca, et al.. (2020). β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism. Cancer Research. 80(22). 5011–5023.
12.
Cerasuolo, Marianna, Federica Maccarinelli, Daniela Coltrini, et al.. (2020). Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer. Cancer Research. 80(7). 1564–1577.
13.
Bortolozzi, Roberta, Davide Carta, Elena Mattiuzzo, et al.. (2019). Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones. European Journal of Medicinal Chemistry. 178. 297–314.
14.
Schaafsma, W., Elisabetta Grillo, Michela Corsini, et al.. (2019). Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue. Cells. 8(11). 1457–1457.
15.
Morigi, Rita, Alessandra Locatelli, Alberto Leoni, et al.. (2019). Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents. European Journal of Medicinal Chemistry. 166. 514–530.
16.
Roncato, Francesco, Elena Porcù, Roberto Ronca, et al.. (2018). Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies. Nature Communications. 9(1). 4070–4070.
17.
Ronca, Roberto, Emanuela Di Salle, Arianna Giacomini, et al.. (2013). Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells. Molecular Cancer Therapeutics. 12(12). 2760–2771.
18.
Belleri, Mirella, Roberto Ronca, Daniela Coltrini, et al.. (2013). Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy. Brain. 136(9). 2859–2875.
19.
Leali, Daria, Patrizia Alessi, Daniela Coltrini, et al.. (2011). Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone–Regulated Tumors. Molecular Cancer Therapeutics. 10(9). 1600–1610.
20.
Ronca, Roberto, Patrizia Benzoni, Daria Leali, et al.. (2010). Antiangiogenic Activity of a Neutralizing Human Single-Chain Antibody Fragment against Fibroblast Growth Factor Receptor 1. Molecular Cancer Therapeutics. 9(12). 3244–3253.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Qiang Wang Breakdown of academic impact, for papers by Antonino Passaniti Breakdown of academic impact, for papers by Karen E. Pollok Breakdown of academic impact, for papers by Anna‐Karin Olsson Breakdown of academic impact, for papers by Betty Chang Breakdown of academic impact, for papers by Aldo M. Roccaro Breakdown of academic impact, for papers by Donald L. Durden Breakdown of academic impact, for papers by Girolamo Ranieri Breakdown of academic impact, for papers by Diane R. Bielenberg Breakdown of academic impact, for papers by Grazia Ambrosini